Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Amino acid challenge in patients with cirrhosis: A model for the assessment of treatments for hepatic encephalopathy

Lookup NU author(s): Dr Andrew Douglass, Dr Christopher Record

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Background/Aims: To mimic episodic hepatic encephalopathy after gastrointestinal bleeding under controlled conditions, cirrhotic patients were challenged with an amino acid mixture of comparable composition to haemoglobin. Methods: Basal EEG, psychometric score (HE test), reaction times and venous blood ammonia were recorded. Following a 54 or 108 gm oral amino acid challenge, blood ammonia levels and EEG were recorded at 30-min intervals, and psychometric testing was repeated at 180 min. Ten controls (57 ± 2) and 31 cirrhotics (52 ± 2) of which 21 were Child's grade A or B and 10 grade C underwent the challenge. Nine had a transjugular intrahepatic porta-systemic shunt in situ. Results: Seventeen patients had abnormal baseline HE scores. Basal blood ammonia and reaction time A were significantly greater in patients (52 ± 5 μmol/l and 478 ± 20 ms, respectively) than controls (19 ± 2 μmol/l and 372 ± 14 ms) (P < 0.001). Following the challenge, in patients with advanced liver disease (Child's grade B and C) the slowing of reaction time A (+85 ± 38 and +71 ± 31 ms, respectively; P < 0.03) and EEG (ratio of slow to fast wave activity +0.31 ± 0.12 and +0.58 ± 0.19; P < 0.02) were significantly greater than in controls (-3.3 ± 8 ms and 0.00 ± 0.03, respectively). Patients with an abnormal basal HE score had the most pronounced changes (reaction time A +110 ± 39 ms, P < 0.01, EEG +0.52 ± 13, P < 0.01, respectively). The change in EEG ratio correlated with the dose of amino acid administered (r = 0.96; P < 0.008). Conclusion: The amino acid challenge constitutes a reproducible human model of episodic, Type C hepatic encephalopathy unaffected by the complications usually encountered in clinical practice. © 2001 European Association for the Study of the Liver. Published by Elsevier Science B.V.


Publication metadata

Author(s): Douglass A; Record C; Al Mardini H

Publication type: Article

Publication status: Published

Journal: Journal of Hepatology

Year: 2001

Volume: 34

Issue: 5

Pages: 658-664

ISSN (print): 0168-8278

ISSN (electronic): 1600-0641

Publisher: Elsevier BV

URL: http://dx.doi.org/10.1016/S0168-8278(01)00004-6

DOI: 10.1016/S0168-8278(01)00004-6

PubMed id: 11434611


Altmetrics

Altmetrics provided by Altmetric


Share